194 related articles for article (PubMed ID: 38202650)
1. An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and
Afzal O; Ahsan MJ
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202650
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)-
Ahsan MJ; Gautam K; Ali A; Ali A; Altamimi ASA; Salahuddin ; Alossaimi MA; Lakshmi SVVNSM; Ahsan MF
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836779
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, ADME, and Anticancer Studies of Newer
Agarwal M; Afzal O; Salahuddin ; Altamimi ASA; Alamri MA; Alossaimi MA; Sharma V; Ahsan MJ
ACS Omega; 2023 Aug; 8(30):26837-26849. PubMed ID: 37593245
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Activity and In Silico ADMET Properties of 2,4,5-Trisubstitutedthiazole Derivatives.
Al-Jaidi BA; Telfah ST; Bardaweel SK; Deb PK; Borah P; Venugopala KN; Bataineh YA; Al Khames Aga QA
Curr Drug Metab; 2021; 22(7):532-536. PubMed ID: 33334285
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
6. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
7. Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studies.
Nawaz Z; Riaz N; Saleem M; Iqbal A; Abida Ejaz S; Bashir B; Muzaffar S; Ashraf M; Aziz-Ur-Rehman ; Sajjad Bilal M; Krishna Prabhala B; Sajid S
Bioorg Chem; 2024 Feb; 143():106984. PubMed ID: 38056389
[TBL] [Abstract][Full Text] [Related]
8. Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: Design, synthesis and biological evaluation.
Amin NH; El-Saadi MT; Abdel-Fattah MM; Mohammed AA; Said EG
Bioorg Chem; 2023 Jun; 135():106496. PubMed ID: 36989735
[TBL] [Abstract][Full Text] [Related]
9. Investigations of
Bashir B; Riaz N; Ejaz SA; Saleem M; Iqbal A; Ashraf M; Ejaz S; -Rehman AU; Aziz M; Bhattarai K
J Biomol Struct Dyn; 2023; 41(24):15549-15568. PubMed ID: 36946200
[TBL] [Abstract][Full Text] [Related]
10. 5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
El-Adl K; Sakr H; Nasser M; Alswah M; Shoman FMA
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000079. PubMed ID: 32515896
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
[TBL] [Abstract][Full Text] [Related]
12. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
13. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Novel Thiophene/Hydrazones: In Vitro and In Silico Studies against Pancreatic Cancer.
Coskun GP; Ozhan Y; Dobričić V; Bošković J; Reis R; Sipahi H; Sahin Z; Demirayak S
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242684
[TBL] [Abstract][Full Text] [Related]
15. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.
Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA
Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598
[TBL] [Abstract][Full Text] [Related]
16. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
17. Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects.
Mohamed HS; Abdelgawad MA; Hegab M; Hamza ZS; Nagdy AM; Ahmed SA; Ahmed OM; Ghoneim MM
Curr Org Synth; 2023; 20(3):339-350. PubMed ID: 36214306
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
[TBL] [Abstract][Full Text] [Related]
19. Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF
Ali EMH; Mersal KI; Ammar UM; Zaraei SO; Abdel-Maksoud MS; El-Gamal MI; Haque MM; Das T; Kim EE; Lee JS; Lee KH; Kim HK; Oh CH
Eur J Pharm Sci; 2022 Apr; 171():106115. PubMed ID: 34995782
[TBL] [Abstract][Full Text] [Related]
20. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]